Article
FDA News
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Wilmer Eye Institute marks 100 years: honoring the past, shaping the future
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Q&A: Kira Manusis, MD, on how the Center for Refractive Solutions is redefining patient care at NYEE
(EyePod) From idea to impact: Navigating ophthalmic innovation
Formosa Pharmaceuticals grants Harrow commercial rights in US to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia
Q&A: Sunir Garg, MD, shares insights on using chlorhexidine for anti-sepsis